US Periodontal Disease Treatment Market

<div class="space_bet_content"> <p class="font16"> This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.</p> <h2 class="subhead_name"> Secondary Research</h2> <p class="font16"> The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&amp;B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study , International Diabetes Federation (IDF), and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the US periodontal disease treatment market study. It was also used to obtain important information about the key players and market classification &amp; segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.</p> <h2 class="subhead_name"> Primary Research</h2> <p class="font16"> In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology &amp; innovation directors, and related key executives from various key companies and organizations in the US periodontal disease treatment market. The primary sources from the demand side include pharmaceutical, biopharmaceutical companies, contract development and manufacturing organizations, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends &amp; key market dynamics.</p> <p class="subhead_name text-left"> <a class="c-blueL" href="/pdfdownloadNew.asp?id=201891912">To know about the assumptions considered for the study, download the pdf brochure</a></p> <div class="row mt-4 bg-gray"> <h2 class="font32 my-4"> Market Size Estimation</h2> <p class="font16"> For the market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the US periodontal disease treatment market. All the major product manufacturers were identified at the country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the US periodontal disease treatment market was split into various segments and sub-segments based on:</p> <ul> <li> List of major players operating in the products market at the regional and/or country level</li> <li> Product mapping of various US periodontal disease treatment manufacturers at the regional and/or country level</li> <li> Mapping of annual revenue generated by listed major players from pain management devices(or the nearest reported business unit/product category)</li> <li> Revenue mapping of major players to cover at least 70-75% of the market share as of 2023</li> <li> Extrapolation of the revenue mapping of the listed major players to derive the market value of the respective segments/subsegments</li> <li> Summation of the market value of all segments/subsegments to arrive at the point-of-care&nbsp; diagnostics market</li> </ul> <p class="font16"> The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.</p> <div class="col-12 col-md-12 py-4"> <img alt="" class="img-fluid w-100 rep_pg_modal_img" src="/Images/periodontal-disease-treatment-market-Top-Down.webp" /></div> <div class="col-12 col-md-12 mb-4"> <h2 class="subhead_name"> Data Triangulation</h2> <p class="font16"> After arriving at the overall size of the US periodontal disease treatment market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.</p> </div> </div> <div class="my-4"> <div class="row"> <div class="col-12 col-md-6 mt-4"> <h2 class="subhead_name"> Market Definition</h2> <p class="font16"> US periodontal disease treatment refers to the medical interventions aimed at preventing, controlling, and treating the inflammation and damage caused by infections of the structures around the teeth, including the gums, periodontal ligament, and alveolar bone. Treatments typically range from non-surgical methods such as scaling and root planing (deep cleaning) to surgical procedures like flap surgery or bone grafting, depending on the severity of the disease. The goal is to eliminate the bacterial infection and halt the progression of the disease, thereby preserving the teeth and surrounding tissues.</p> </div> <div class="col-12 col-md-6 mt-4"> <h2 class="subhead_name"> Stakeholders</h2> <ul class="rd-of-cci"> <li> Manufacturers and distributors of medical devices</li> <li> US periodontal disease Treatment manufacturers</li> <li> Contract manufacturers of dental equipment</li> <li> Distributors of dental equipment</li> <li> Research and consulting firms</li> <li> Raw material suppliers of US periodontal disease Treatment</li> <li> Dental hospitals and clinics</li> <li> Dental laboratories and associations</li> <li> Dental practitioners</li> <li> Dental laboratory technicians</li> <li> Healthcare institutions</li> <li> Diagnostic laboratories</li> <li> Hospitals and clinics</li> <li> Academic institutions</li> <li> Research institutions</li> <li> Government associations</li> <li> Market research and consulting firms</li> <li> Venture capitalists and investors</li> </ul> </div> <div class="col-12 col-md-12 mt-4"> <h2 class="subhead_name"> Report Objectives</h2> <ul class="rd-of-cci"> <li> To define, describe, and forecast the US periodontal disease treatment market based on disease type, treatment type, end user, and region.</li> <li> To forecast the market size based on five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East &amp; Africa.</li> <li> To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, porter&rsquo;s five forces, patent analysis, key stakeholders and buying criteria, and conference and events.</li> <li> To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)</li> <li> To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall US periodontal disease treatment market.</li> <li> To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders.</li> <li> To strategically profile key players in the US periodontal disease treatment market and comprehensively analyze their core competencies.</li> <li> To track and analyze competitive developments such as product launches &amp; approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall US periodontal disease treatment market.</li> <li> To benchmark players within the market using the proprietary &ldquo;Competitive Evaluation Matrix&rdquo; framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy</li> <li> To analyze the generative AI&nbsp; impact on the US periodontal disease treatment market</li> </ul> </div> </div> </div> </div>